IQ Consortium
Organization of pharmaceutical and biotechnology companies with a mission of advancing science and technology.
Virtual Event
Current Industry Practices on Immunogenicity Risk Assessment and Data Analysis
May 15 @ 11:00 am - 12:00 pm
Virtual Event
Presented by the Immunogenicity Working Group
Sponsored by the Clinical Pharmacology Leadership Group
The Immunogenicity Working Group at IQ Consortium conducted an industry-wide survey with close to 100 molecules
with different modalities at different stages of drug development.
The objective of this two-part webinar series is to (1) understand the immunogenicity risk assessment and (2) quantitative evaluations of immunogenicity assessment.
